215 results
P
pacientes con COVID-19
I/C
inhibidores de la enzima convertidora de angiotensina, bloqueadores del receptor de angiotensina II, placebo o ningún tratamiento
O
efectos sobre la COVID-19
P
patients with de novo IAs
I/C
systematic review and meta-analysis of existing de novo IA cohorts, initial IAs in the middle cerebral artery
O
de novo IAs
P
adult women with stress urinary incontinence (SUI)
I/C
bottom-up tension-free vaginal tape (TVT), inside-out tension-free vaginal tape - obturator (TVT-O)
O
incontinence episodes, subjective patient reported effect, incontinence-related quality of life, leg or groin pain, chronic pelvic or lower abdominal pain, bladder perforations, de novo urgency, re-operations, infection, hematoma, pain during sexual intercourse, sexual function
P
I/C
l, o, w, -, l, e, v, e, l, , a, r, s, e, n, i, c, , (, A, s, ), , c, o, n, c, e, n, t, r, a, t, i, o, n, , i, n, , d, r, i, n, k, i, n, g, , w, a, t, e, r, d, r, i, n, k, i, n, g, , w, a, t, e, r, , A, s, , c, o, n, c, e, n, t, r, a, t, i, o, n, s, , l, o, w, e, r, , t, h, a, n, , t, h, e, , W, H, O, , p, r, o, v, i, s, i, o, n, a, l, , g, u, i, d, e, l, i, n, e, , v, a, l, u, e, , (, 1, 0, , µ, g, /, L, )
O
p, o, o, l, e, d, , a, s, s, o, c, i, a, t, i, o, n, , b, e, t, w, e, e, n, , t, h, e, , r, e, l, a, t, i, v, e, , r, i, s, k, , o, f, , e, a, c, h, , c, a, r, d, i, o, v, a, s, c, u, l, a, r, , d, i, s, e, a, s, e, , (, C, V, D, ), , e, n, d, p, o, i, n, t, , a, n, d, , l, o, w, -, l, e, v, e, l, , A, s, , c, o, n, c, e, n, t, r, a, t, i, o, n, , i, n, , d, r, i, n, k, i, n, g, , w, a, t, e, r
P
FOAM SURFACES
I/C
ALTERNATING PRESSURE AIR SURFACES, REACTIVE AIR SURFACES, REACTIVE FIBER SURFACES, REACTIVE GEL SURFACES, REACTIVE FOAM AND GEL SURFACES, REACTIVE WATER SURFACES, ANY SUPPORT SURFACE
O
PRESSURE ULCER INCIDENCE
P
people with non-exudative age-related macular degeneration (AMD)
I/C
photobiomodulation (PBM) therapy, standard care, sham treatment, or no treatment
O
best-corrected visual acuity (BCVA); contrast sensitivity; near vision; low luminance density score; reading speed; vision-related quality of life score; and adverse events such as progression of AMD and conversion to exudative AMD
P
humanos
I/C
reactive surfaces, non-foam and non-air-filled reactive surfaces, other support surfaces
O
pressure ulcer incidence
P
pacientes sometidos a cirugía
I/C
intervenciones con ejercicio, controlados
O
reducción de la sarcopenia
P
older adults without cognitive impairment
I/C
anticholinergic medications, cognitive decline or dementia
O
risk of cognitive decline or dementia